Cite
Serum CD166: A novel hepatocellular carcinoma tumor marker.
MLA
Ma, Lifang, et al. “Serum CD166: A Novel Hepatocellular Carcinoma Tumor Marker.” Clinica Chimica Acta, vol. 441, Feb. 2015, pp. 156–62. EBSCOhost, https://doi.org/10.1016/j.cca.2014.12.034.
APA
Ma, L., Lin, J., Qiao, Y., Weng, W., Liu, W., Wang, J., & Sun, F. (2015). Serum CD166: A novel hepatocellular carcinoma tumor marker. Clinica Chimica Acta, 441, 156–162. https://doi.org/10.1016/j.cca.2014.12.034
Chicago
Ma, Lifang, Jiafei Lin, Yongxia Qiao, Wenhao Weng, Weiwei Liu, Jiayi Wang, and Fenyong Sun. 2015. “Serum CD166: A Novel Hepatocellular Carcinoma Tumor Marker.” Clinica Chimica Acta 441 (February): 156–62. doi:10.1016/j.cca.2014.12.034.